FDA tightens warning of heart issues after J&J COVID vaccine

Amber CoakleyDecember 16, 2021

FILE – A member of the Philadelphia Fire Department prepares a dose of the Johnson & Johnson COVID-19 vaccine at a vaccination site setup in Philadelphia, on March 26, 2021. A government advisory panel is meeting Thursday, Dec. 16, to determine if any restrictions are needed to the Johnson & Johnson COVID-19 vaccine because of rare but serious blood clots. (AP Photo/Matt Rourke, File)

OAN Newsroom
UPDATED 9:47 AM PT – Thursday, December 16, 2021

The FDA is strengthening its warning of possible severe adverse effects of the Johnson & Johnson COVID vaccine. On Wednesday, the federal health agency said the Johnson & Johnson vaccine must not be administered to people with past histories of blood clots and thrombosis.

The FDA also said other adeno-virus based vaccines must not be used in such patients. This came after the Vaccine Adverse Event Reporting System (VAERS) self-reporting system posted almost 20,000 Americans died post-vaccination so far and 100,000 were hospitalized.

Dr. McCullough goes over the latest Vaers numbers and who the vaccine adverse events and deaths are affecting the most. pic.twitter.com/zKfz0y6lSZ

— My Doc is McCullough (@Petersparrot) December 12, 2021

Doctors say vaccine-induced heart problems must be taken seriously.

“So instead of having 11 percent risk of having an acute coronary syndrome in the next five years, that went up to 25 percent risk,” explained Dr. John Campbell, a medical commentator. “Now again, we don’t know much about the group, but that increase from 11 percent to 25 percent is, of course, totally massive. If this were to be applicable to the entire population this would basically mean we’re going to get an unimaginable amount of extra heart attacks.”

Meanwhile, vaccines by Pfizer and Moderna are also under scrutiny in several European countries after reports of heart problems in young vaccinated males.